Study Reveals Alarming Gaps in HER2 Therapy Access for Patients With Breast Cancer
Despite increasing use of HER2-targeting breast cancer
therapies, uptake of these agents persists, according to findings from a
retrospective cohort study. The authors reported that only about 75% of all
hormone receptor-negative (HR–)/HER2-positive ... |